TOPICS:
Abstracts can be submitted under the following Topics
- Translation research and individualized medicine
- Drug Design and Recovery
- Neuroscience
- History of Pharmacy
- Clinical Biology
- Pain
- Cardiovascular System
- Health and Medicines information
- Nephrology and Urology
- Immunology, Inflammation and Bone Metabolism
- Natural Products
- Gastrointestinal System
- Stem Cell Medicine
- Formulation Design and Pharmaceutical Technology
- Metabolism and Diabetes
- Respiratory System
- Regulatory Sciences
- Systems Biology
- Education and Training
- Pharmacy Practice Research
- Sensory System
- Biotechnology
- Cancer
- Health and Medicines information
- Academic Pharmacy
- Rare Diseases
- Molecular Bioimaging
- Infection/Global Infectious Diseases
- Natural Medicine and Traditional East Asian Medicines
- Hospital Pharmacy
- Community Pharmacy
- Regulatory Science
- Industrial Pharmacy
- Pharmacovigilance
- Clinical Biology
- Military and Emergency Pharmacy
- Pediatric Clinical Pharmacology
- Pharmacometrics
- Pediatric Clinical Pharmacology
- Health Economics
- Pharmacokinetics
- Genomics/Pharmacogenomics/Personalized Medicine
- Pharmacokinetics
- Toxicology
- Global Health
- Mental Health and Addiction
- Biomarkers and Translational Tools
- Drug Utilization and Outcomes
- Pharmacometabolics
ABSTRACT SUBMISSION
DEADLINE:
All Abstracts for review must be submitted before the 15th of April at 23:50 EET.
- Abstract submissions can only be made electronically through the congress website.
- The abstract should be structured in clear and concise paragraphs under the following subheadings:
Title, Topic area (This is to ensure your abstract is placed in the right category. We welcome abstracts from a range of topics listed above, kindly refer to the list provided to choose the most appropriate topic area for your abstract)
Objective, Background information, Method, Results and Conclusion
- Abstracts should also contain keywords that best define the chosen Topic area
- Abstracts must be in English and should contain no more than 350 words. N.B excluding the names of Authors and Co-authors, Title of the Abstract (Do not include email, phone number or website address to the Title), and excluding the name(s) of the companies of the original Author or Co-authors.
- Abstracts should contain original and previously unpublished results.
- All Authors and Co-authors must be listed.
- One image (figure, table, chart or illustration) can be attached to the abstract. No end-notes or citations are allowed in the Abstract.
- Acceptable data formats: PDF, JPG, GIF, PNG. Maximum file size: 5MB, 600(w) x 800(h) pixels.
- The first author must present his/her presentation.
- The first author must complete pre-registration when submitting an abstract.
- Notification of abstract acceptance will be sent via E-mail no later than 25th of April
- The Scientific Committee reserves the right to reject any abstract it considers not to be appropriate in relation to the congress criteria.
- Accepted abstracts shall be presented as posters, and only a limited number of requests for oral presentation will be granted. The final decision will be made by the Scientific Committee of the congress.